Central, prospective detection of homologous recombination repair gene mutations (HRRm) in tumour tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC) screened for the PROfound study
Year: 2019
Type: article
Source: Annals of Oncology
Institutions: Institute of Cancer Research, Université Paris-Sud, Institut Gustave Roussy, Centre Hospitalier de l’Université de Montréal, Carolina Urologic Research Center, Peter MacCallum Cancer Centre, Radboud University Nijmegen, Radboud University Medical Center, University of Alberta, Cross Cancer Institute, Institut Bergonié, Istanbul University-Cerrahpaşa, Istanbul University, National Cancer Center Hospital East, University of Newcastle Australia, Yonsei University, Yonsei University Health System, AstraZeneca (United States), AstraZeneca (United Kingdom), Merck & Co., Inc., Rahway, NJ, USA (United States), Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2977569941